A new study suggests that acute myeloid leukemia (AML) may occur in part because abnormally low levels of a particular microRNA result in the over-activity of two genes important to the disease.

The research involved 85 patients with AML and gene mutations called NPM1, seen in about one-third of adult AML cases, and FLT3.

The findings suggest new therapeutic targets for treating the disease and should improve the understanding of AML.

...